These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2093 related articles for article (PubMed ID: 28174608)

  • 1. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
    Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; van der Laan BF; van Criekinge W; de Meyer T; Denil S; Wisman GB; Roodenburg JL; Schuuring E
    Genes Chromosomes Cancer; 2016 Jan; 55(1):45-59. PubMed ID: 26391330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
    BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
    Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
    Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel.
    Morandi L; Gissi D; Tarsitano A; Asioli S; Gabusi A; Marchetti C; Montebugnoli L; Foschini MP
    Clin Epigenetics; 2017; 9():85. PubMed ID: 28814981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
    Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
    Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
    Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
    Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
    Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
    Fu J; Su Y; Liu Y; Zhang XY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
    [No Abstract]   [Full Text] [Related]  

  • 16. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
    Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
    Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
    Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
    Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.
    Foy JP; Pickering CR; Papadimitrakopoulou VA; Jelinek J; Lin SH; William WN; Frederick MJ; Wang J; Lang W; Feng L; Zhang L; Kim ES; Fan YH; Hong WK; El-Naggar AK; Lee JJ; Myers JN; Issa JP; Lippman SM; Mao L; Saintigny P
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1027-35. PubMed ID: 26342026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter Methylation of Cancer Stem Cell Surface Markers as an Epigenetic Biomarker for Prognosis of Oral Squamous Cell Carcinoma.
    Han YK; Park HY; Park SG; Hwang JJ; Park HR; Yi JM
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 105.